Samyukta Mullangi, MD, MBA, medical director at Thyme Care, explained her excitement to meet with industry leaders, share best practices, and learn about new innovations in oncology care at Patient-Centered Oncology Care® (PCOC) 2024.
Patient-Centered Oncology Care® (PCOC) 2024, a leading oncology conference, is set to convene in Nashville, Tennessee, from September 12th to 13th. This meeting will bring together top experts in the field to discuss cutting-edge advancements aimed at improving patient outcomes and quality of life in oncology care.
Samyukta Mullangi, MD, MBA, medical director at Thyme Care will be participating in a panel discussion about the new principal illness navigation codes (PIN) and their potential impact on the enhancing oncology model. The panel will discuss whether these codes will create a significant change in practice or if they are just a starting point.
This transcript has been lightly edited for clarity.
Transcript
What are you most looking forward to at Patient-Centered Oncology Care, or PCOC, next month?
I love the PCOC conference. Every year, I think it is such an opportunity to meet with industry leaders across oncology, thinking about where are the areas of innovation, interest, energy, investment, and really sharing notes.
I think there are not enough opportunities to be honest in terms of knowledge sharing, but AJMC's PCOC fulfills a really important niche in doing that. I think sharing best practices is just lifting all boats, so I'm very excited to see everybody.
Could you give a preview of what will be discussed during your panel, "The New Math: What Does PIN Mean to the Enhancing Oncology Model?"
Yeah, I'm in conversation with several community practice leaders talking about the new principal illness navigation codes that CMS introduced in January of this year. Those codes came with a big wave of excitement because formerly, there wasn't really a formal reimbursement structure for patient-oriented navigation, specifically. Even though there were sort of echoes of this within existing programs like the [Chronic Care Management] and [Principal Care Management programs], but I think there is a unique opportunity here.
What we're going to be talking about is whether these codes are going to create that wave of change, or whether they are a starting point, but potentially not enough to change practice. I think that's a very thorny and interesting conversation to get into so I'm really looking forward.
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
February 21st 2025The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Read More
Politics vs Science: The Future of US Public Health
February 4th 2025On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Listen
Adapting ACA Access Amid Medicaid Transition and Policy Reversals: Molly Dean
February 19th 2025As enrollment shifts to the Affordable Care Act (ACA) marketplace following the unwinding of Medicaid and the Trump administration begins to implement health policy changes, Molly Dean, MSW, Siftwell's policy advisor, shares insight on how to adapt.
Read More
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
February 21st 2025The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Read More
Politics vs Science: The Future of US Public Health
February 4th 2025On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Listen
Adapting ACA Access Amid Medicaid Transition and Policy Reversals: Molly Dean
February 19th 2025As enrollment shifts to the Affordable Care Act (ACA) marketplace following the unwinding of Medicaid and the Trump administration begins to implement health policy changes, Molly Dean, MSW, Siftwell's policy advisor, shares insight on how to adapt.
Read More
2 Commerce Drive
Cranbury, NJ 08512